Biomeditsina va amaliyot jurnali, 2022 №5
Subject of the article
ANALYSIS OF THE SOCIO-ECONOMIC ASPECTS OF THE NEW CORONAVIRUS INFECTION (COVID-19) (480-484)
Authors
Saodat Ulmasova.
Institution
Tashkent Pediatric Medical Institute
Abstract
When determining the socio-economic significance of a new coronavirus infection, the main approach is to assess the social and economic damage of the disease, taking into account the cost of all treatment and diagnostic measures. In this research, when calculating economic indicators, values were chosen that include the costs of outpatient care, hospitalization, diagnostics and treatment. When calculating, the cost of each undertaken event was multiplied by the frequency of its implementation. As a result of the study, the economic efficiency of diagnostic and treatment measures for COVID- 19 in the studied patients aged 18 to 65 years was evaluated.
Key words
COVID-19, coronavirus infection, measures against the epidemic, epidemiology
Literature
Мусабаев Э.И., Рахимов Р.А., Шарапов Б.М. и др. Временные рекомендации по профилактике, диагностике и лечению новой короновирусной инфекции 2019-nCov. Ташкент. 2020. 6. Мустафаев Х.М., Маматкулов И.Х. Организация противоэпидемических мероприятий при COVID-19 и допущенные просчеты в Узбекистане // Журнал Инфекция, Иммунитет и Фармакологии. –Ташкент, 2021. -№1. -С.109. 7. Ўзбекистон Республикаси Бош давлат санитария врачининг “COVID-19 коронавирус инфекциясини республика ҳудудига кириб келиши ва тарқалишининг олидини олиш бўйича тадбирларни янада такомиллаштириш тўғрисида”ги 1-7-сонли қарорлари. 8. Платонова Т.А., Голубкова А.А., Карбовничая Е.А., Смирнова С.С. Особенности формирования гуморального иммунитета у лиц с различными клиническими проявлениями COVID-19. // Эпидемиология и Вакцинопрофилактика. 2021.V-20. №1. С.20-25. 9. Обзор нового коронавируса 2019 года (COVID-19), СДС, 1 февраля 2020 г. Источник контента: Национальный центр иммунизации и респираторных заболеваний (NCIRD), Отдел вирусных заболеваний; https://www.cdc.gow/coronavirus/COVID-19/summary.html. 10. Zhu F-C, Guan X-H, Li Y-H. Immunogenicity and safety of a recombinant adenovirus type-5- vectored COVID-19 vaccine in healthy adults aged 18 years or older: a randomised, doubleblind, placebocontrolled, phase 2 trial // Lancet 2020; 396. - P.479-88. 11. World health statistics 2021: monitoring health for the SDGs, sustainable development goals. Geneva: World Health Organization; 2021. 12. Hajibeygi, R., Mirghazanfari, S. M., Pahlavani, N., Jalil, A. T., Alshahrani, S. H., Rizaev, J. A., ... & Yekta, N. H. (2022). Effect of a diet based on Iranian traditional medicine on inflammatory markers and clinical outcomes in COVID-19 patients: A double-blind, randomized, controlled trial. European Journal of Integrative Medicine, 102179